ACCESS 2 IMMUNOASSAY SYSTEM 81600N

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2007-05-07 for ACCESS 2 IMMUNOASSAY SYSTEM 81600N manufactured by Beckman Coulter, Inc..

Event Text Entries

[638142] A customer contacted beckman coulter inc. (bci) regarding erroneously low prostate specific antigen (psa) results from two (2) different patient samples that were generated by the access 2 instrument. The initial psa results were: 3. 65ng/ml for patient a and 1. 85ng/ml for patient b. The results were not reported out of the lab. The original samples were retested for psa and the repeated results were higher for both patients: psa results for patient a were: 5. 37ng/ml and 5. 61ng/ml. Psa result for patient b was 5. 13ng/ml. Per customer, the higher psa results for patient a were confirmed at a different lab. Additionally, customer provided a previous psa result of 9. 11ng/ml which was obtained for this patient a few months earlier. The customer did not receive any report of patient injury requiring medical intervention, or change to patient treatment attributed or connected with this event.
Patient Sequence No: 1, Text Type: D, B5


[7976546] Qc was within specifications before the event. Qc performed in 2007, after maintenance, was within specifications for levels i and ii. Level iii was out of specifications high initially and upon repeat. The samples are collected at offsite physician's offices, in plastic, bd, serum separator tubes (sst). A field service engineer (fse) was dispatched to the customer's lab: while on-site, the fse observed in-coming specimens and questioned their integrity. The specimens were centrifuged at 1,000g. The fse recommended increasing centrifuge speed to 1,300g. The fse printed and discussed pre-analytical sample handling data with the customer. The fse replaced upper and lower precision pump seals. The fse installed new transducer and performed transducer adjustment procedure. The fse performed diagnostic testing with passing results. The fse verified the instrument per established rocedures. In a follow-up with the customer five days later, they had not had any further issues with psa results. The customer stated they were unaware that the collection tubes were changed to plastic tubes from glass tubes. They also stated, they were unaware these tubes needed to be inverted after blood collection. A pre-analytical sample handling packet, and a cd presentation was sent to customer in assisting the training of staff on proper sample handling. A clear root cause has not been determined for this event. A malfunction will be assumed for the purpose of this report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2122870-2007-00107
MDR Report Key860942
Report Source05
Date Received2007-05-07
Date of Report2007-05-07
Date of Event2007-04-18
Date Mfgr Received2007-04-18
Device Manufacturer Date2003-10-01
Date Added to Maude2007-06-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactNORA ZEROUNIAN, MANAGER
Manufacturer Street200 S. KRAEMER BLVD PO BOX 8000, MAIL STOP: W-110
Manufacturer CityBREA CA 928228000
Manufacturer CountryUS
Manufacturer Postal928228000
Manufacturer Phone7149613634
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Remedial ActionIN
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameACCESS 2 IMMUNOASSAY SYSTEM
Generic NameDISCRETE PHOTOMETRIC CHEMISTRY ANALYZER
Product CodeNAF
Date Received2007-05-07
Model NumberACCESS 2 IMMUNOASSAY SYSTEM
Catalog Number81600N
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrN
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key844081
ManufacturerBECKMAN COULTER, INC.
Manufacturer Address1000 LAKE HAZELTINE DR. CHASKA MN 55318 US


Patients

Patient NumberTreatmentOutcomeDate
10 2007-05-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.